Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $675.61 billion, total revenue of $168.86 billion and a weighted average PE ratio of 38.61.
Market Cap
675.61B
Revenue
168.86B
Profits
17.5B
PE Ratio
38.61
Profit Margin
10.36%
Dividend Yield
0.24%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 174.19B | -1.46% | 1,307,161 | 45.20B |
| 2 | DHR | Danaher Corporation | 127.47B | -0.38% | 2,040,112 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.24B | 0.52% | 408,521 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 36.67B | 0.23% | 1,245,990 | 7.23B |
| 5 | WAT | Waters Corporation | 34.86B | -1.30% | 658,843 | 3.77B |
| 6 | NTRA | Natera, Inc. | 30.37B | -3.27% | 701,507 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 30.29B | 0.22% | 1,239,672 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 24.32B | -3.30% | 1,174,622 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 22.86B | -0.86% | 81,443 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.48B | -0.38% | 657,813 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.76B | 0.06% | 365,579 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.46B | 0.58% | 1,284,960 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.32B | -1.80% | 240,003 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 11.17B | -2.67% | 623,484 | 8.25B |
| 15 | RVTY | Revvity, Inc. | 11.12B | -1.83% | 789,939 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 9.01B | -0.51% | 407,499 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.66B | -0.96% | 1,702,184 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 4.74B | 2.86% | 2,415,677 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 4.65B | 1.48% | 525,531 | 354.54M |
| 20 | SHC | Sotera Health Company | 4.62B | -1.25% | 1,237,915 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.45B | -2.66% | 567,480 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 3.77B | -0.46% | 943,868 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 2.82B | -6.03% | 2,975,200 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.57B | -0.44% | 295,641 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.78B | -1.75% | 1,327,293 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.45B | -2.79% | 1,273,609 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.19B | -2.92% | 327,561 | 412.82M |
| 28 | OPK | OPKO Health, Inc. | 1.07B | -2.07% | 1,506,524 | 581.12M |
| 29 | PSNL | Personalis, Inc. | 1.00B | 1.80% | 1,800,273 | 64.52M |
| 30 | CSTL | Castle Biosciences, Inc. | 626.01M | -1.76% | 115,121 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 530.52M | -0.53% | 181,198 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 409.43M | -6.37% | 999,338 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 364.00M | 4.54% | 341,518 | 120.07M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 181.14M | 3.31% | 383,781 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 153.25M | 2.43% | 20,186 | 96.10M |
| 36 | XGN | Exagen Inc. | 112.83M | 4.24% | 133,952 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 90.59M | -2.72% | 45,383 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 39.98M | -1.02% | 21,318 | 25.83M |
| 39 | MDXH | MDxHealth SA | 28.05M | -6.97% | 554,001 | 110.97M |
| 40 | QUCY | Quantum Cyber N.V. | 21.65M | -8.95% | 2,108,495 | 537.08K |
| 41 | XWEL | XWELL, Inc. | 10.43M | 2.92% | 146,813 | 28.83M |
| 42 | MBAI | Check-Cap Ltd. | 10.13M | 1.46% | 27,356 | - |
| 43 | ADVB | Advanced Biomed Inc. | 7.43M | 12.22% | 79,642 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 6.76M | -8.40% | 166,261 | 5.66M |
| 45 | NDRA | ENDRA Life Sciences Inc. | 5.62M | 2.03% | 12,251 | - |
| 46 | ISPC | iSpecimen Inc. | 3.95M | - | 106,790 | 1.03M |